Literature DB >> 22528235

Expression of IRF-4 and IBP in skin lesions of patients with psoriasis vulgaris.

Anhong Ni1, Hongxiang Chen1, Yan Wu1, Wen Li1, Shanjuan Chen1, Jiawen Li2.   

Abstract

The expression of the interferon regulatory factor 4 (IRF-4) and the IRF-4-binding protein (IBP) in psoriatic skin lesions was investigated. The expression of IRF-4 and IBP in skin lesions of 20 patients with psoriasis vulgaris were immunohistochemically dectected. Normal skin from 10 healthy people was used as normal control. The study showed that expression of IRF-4 was increased significantly in keratinocytes and inflammatory cells in the lesions of psoriasis vulgaris than that in the normal control. The detection revealed that IBP expression in keratinocytes, lymphocytes, hair follicles, and sebaceous glands in normal skin was significantly lower than that in the lesions of psoriasis vulgaris (P<0.05). Both IRF-4 and IBP might be involved in the pathogenesis of psoriasis vulgaris.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22528235     DOI： 10.1007/s11596-012-0050-6

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN： 1672-0733


  18 in total

1.  The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4.

Authors:  Anne Brüstle; Sylvia Heink; Magdalena Huber; Christine Rosenplänter; Christine Stadelmann; Philipp Yu; Enrico Arpaia; Tak W Mak; Thomas Kamradt; Michael Lohoff
Journal:  Nat Immunol       Date:  2007-08-05       Impact factor: 25.606

2.  Keeping autoimmunity in check: how to control a Th17 cell controller.

Authors:  Roza I Nurieva; Chen Dong
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

Review 3.  Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.

Authors:  Jane Hoyt Buckner
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

4.  Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice.

Authors:  Partha S Biswas; Sanjay Gupta; Emily Chang; Li Song; Roslynn A Stirzaker; James K Liao; Govind Bhagat; Alessandra B Pernis
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

5.  IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype.

Authors:  Magdalena Huber; Anne Brüstle; Katharina Reinhard; Anna Guralnik; Gina Walter; Azita Mahiny; Eberhard von Löw; Michael Lohoff
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

6.  Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.

Authors:  Sheng Xiao; Hulin Jin; Thomas Korn; Sue M Liu; Mohamed Oukka; Bing Lim; Vijay K Kuchroo
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

7.  Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis.

Authors:  Roberta Caruso; Elisabetta Botti; Massimiliano Sarra; Maria Esposito; Carmine Stolfi; Laura Diluvio; Maria Laura Giustizieri; Valentina Pacciani; Annamaria Mazzotta; Elena Campione; Thomas T Macdonald; Sergio Chimenti; Francesco Pallone; Antonio Costanzo; Giovanni Monteleone
Journal:  Nat Med       Date:  2009-08-16       Impact factor: 53.440

8.  Expression of Th17 cytokines in skin lesions of patients with psoriasis.

Authors:  Jiawen Li; Xu'e Chen; Zhixiang Liu; Qing Yue; Houjun Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-06

9.  SLAT/Def6 plays a critical role in the development of Th17 cell-mediated experimental autoimmune encephalomyelitis.

Authors:  Ann J Canonigo-Balancio; Camille Fos; Thomas Prod'homme; Stéphane Bécart; Amnon Altman
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

10.  IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor.

Authors:  Qinzhong Chen; Wen Yang; Sanjay Gupta; Partha Biswas; Paula Smith; Govind Bhagat; Alessandra B Pernis
Journal:  Immunity       Date:  2008-12-08       Impact factor: 31.745
View more
  4 in total

1.  Exacerbated Imiquimod-Induced Psoriasis-Like Skin Inflammation in IRF5-Deficient Mice.

Authors:  Momoko Nakao; Tomomitsu Miyagaki; Makoto Sugaya; Shinichi Sato
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

2.  Chromatin Looping Links Target Genes with Genetic Risk Loci for Dermatological Traits.

Authors:  Chenfu Shi; Helen Ray-Jones; James Ding; Kate Duffus; Yao Fu; Vasanthi Priyadarshini Gaddi; Oliver Gough; Jenny Hankinson; Paul Martin; Amanda McGovern; Annie Yarwood; Patrick Gaffney; Steve Eyre; Magnus Rattray; Richard B Warren; Gisela Orozco
Journal:  J Invest Dermatol       Date:  2021-02-17       Impact factor: 8.551

Review 3.  Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases.

Authors:  Alessia Capone; Elisabetta Volpe
Journal:  Front Immunol       Date:  2020-03-12       Impact factor: 7.561

4.  Thalidomide Exerts Anti-Inflammatory Effects in Cutaneous Lupus by Inhibiting the IRF4/NF-ҡB and AMPK1/mTOR Pathways.

Authors:  Sandra Domingo; Cristina Solé; Teresa Moliné; Berta Ferrer; Josefina Cortés-Hernández
Journal:  Biomedicines       Date:  2021-12-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.